Treatment and Prophylaxis Guidelines – Where are we up to? Dr Jonathan Sandoe, Consultant Microbiologist, Leeds Management of infections in the vascular.

Slides:



Advertisements
Similar presentations
Surgical site infection
Advertisements

Infection Control in CKD A Culture of Safety Leona Dinnan, RN, CDN.
Infection After ACL Reconstruction H. Makhmalbaf MD Consultant Orth.& Knee Surgeon Mashhad University of Medical Sciences.
Antimicrobial Resistance in N. gonorrhoeae – An Overview 2014 INTRODUCTION Progressive antimicrobial resistance in Neisseria gonorrhoeae is an emerging.
The Diabetic Foot A Medical View Associate Professor Jonathan Shaw.
Febrile Neutropenia Allison Ferrara, MD Princeton Baptist Medical Center Baptist Health Systems Alabama.
Canadian Diabetes Association Clinical Practice Guidelines In-Hospital Management of Diabetes Chapter 16 Robyn Houlden, Sara Capes, Maureen Clement, David.
Infective endocarditis
When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.
+ A Vitamin T Overdose? : An audit of piperacillin/ tazobactam use at Royal Perth Hospital Amelia Davis and Matthew Hanson Contributors: Dr Susan Benson,
National Changes in Antibiotic Policy R. Andrew Seaton Consultant Physician Lead doctor Antimicrobial Management Team, NHS GG&C.
In The Name of Allah. Guidelines For Surgical Chemoprophylaxis By: Dr. M. Minaiyan Dept. of Pharmacology, IUMS.
Drug and Therapeutics Committee Session 7A. Identifying Problems with Medicine Use: Indicator Studies.
Antimicrobial Stewardship Program JMH House staff Orientation 2012 Lilian Abbo, MD Assistant Professor Clinical Infectious Diseases Laura Smith, PharmD.
Complications and principles of treatment of infective endocarditis incl. prognosis and antibiotic prophylaxis for endocarditis.
A Retrospective Analysis of the Impact of Intramuscular Antibiotics for the Treatment of ‘Borderline’ Foot Infections - an Admission Avoidance Strategy.
IDSA / ISAP / FDA Workshop on Antimicrobial Drug Development Update 2004 Edward Cox, MD MPH ODE IV Center for Drug Evaluation and Research US Food and.
June ‘XX Presents to Beaumont A&E c/o Abdominal Pain B/G: Known AAA Radiating through to the back Constant for 24 hrs Vomit x 6 Fever, Malaise No Hx of.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
Antimicrobial Stewardship St. Mary’s Hospital Infection Control Committee.
Preventing Transmission of C. difficile: Practice Elise Tamplin, M(ASCP), MPH, CIC Brigham & Women’s Hospital.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Efficacy and safety of moxifloxacin in patients with secondary peritonitis Post-hoc pooled analysis of 4 prospective multi-centre phase III RCTs in adult.
Joint Hospital Surgical Ground Round The Management of Mycotic Aneurysm Chan Hoi Yee Princess Margaret Hospital.
Surgical Wounds and Antimicrobial prophylaxis Dr. Philip G. Murphy Consultant in Medical Microbiology Adelaide and Meath Hospitals incorporating the National.
Introduction to Antimicrobials. General Terms Chemotherapy Antibiotic – substance produced by a microbe that may harm another microbes Antimicrobial –
PRINCIPLES OF PROPHYLAXIS OF INFECTION 1)Procedure should have significant risk of infection 2)Choose correct antibiotic 3)Antibiotic plasma level must.
The Bone & Joint Program at the University of Louisville: The Bone and Joint Infection (BAJIO) Database Diana Christensen MD, Julie Harting PharmD, Cheick.
Zunilda Djanun*, Rudyanto S**, Yulia Rosa***, *Dept. Clinical Pharmacology FMUI/CMH, **ICU CMH, *** Dept. Clinical Microbiology FMUI.
VCU DEATH AND COMPLICATIONS CONFERENCE. Introduction  Complication  Graft infection  Procedure  Femoral-femoral bypass  Primary Diagnosis  Left.
Hemodialysis access: guidelines, evidence and controversies Marc R Lilien, MD, PhD Pediatric nephrologist.
Early and late onset vascular graft infections – Surgical dilemmas Pranav Somaiya Developmental Lead, Proteomics,NPIMR(affl. UCL) SpR, Vascular Surgery,
John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois.
1. PRESENTED BY: DR. HAMIDREZA NAJARI INFECTIOUS DISEASE SPECIALIST ASSISTED PROFESSOR OF QAZVIN UNIVERSITY OF MEDICAL SCIENCES Diabetic foot.
Prosthetic heart valves: management of usual and unusual complications January 14 th, h-15h30.
Guideline for the Diagnosis and Management of Adults in LTC with Urinary Tract Infection (Part 2) This is intended as a guide for evidence-based decision-making.
Cellulitis Darren Wilson Antibiotic Pharmacist Royal Bournemouth Hospital.
The What and Why of Antimicrobial Stewardship Kelly Kauber, MPH Antimicrobial Stewardship in LTC, May 12th, 2016.
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
Principles of prevention of infection Yaser Baroud.
1 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital DIABETES Care; Aug 2006; 29,8 : FM R1 임혜원.
MANAGEMENT OF NEUTROPENIC FEVERS IN CANCER PATIENTS Jerry Yu.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
The MSK Referral System Dr Louise Pollard Consultant Rheumatologist Lewisham and Greenwich NHS Trust.
Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Musculoskeletal Disorders.
Nosocomial Antibiotic Resistant Organisms
Antimicrobial Stewardship
Endocarditis Tutoring
Endocarditis: Treatment
GUIDELINES FOR PROSTHETIC JOINT INFECTION CID 2013
Clinical Microbiology and Infection
Therapeutics III Tutoring February 10th, 2016
DCD Hope, H Wang, R Anders, P Villa, C Kong
Antibiotics: Handle with care!
Orthopaedic WH - Surgical Antibiotic Prophylaxis
Clinical Microbiology and Infection
Presentation Title 36pt Arial Bold
Infections in Surgical Patients What about prophylaxis?
Specific Therapy The American Heart Association recently published new guidelines for the management of IE, including specific treatment recommendations.
Risk factors for surgical site Infections
Surgical Infections What about Treatment?.
Antimicrobial ward round
ANTIBIOTIC STEWARDSHIP PROGRAM
Selective application of sartorius muscle flaps and aggressive staged surgical debridement can influence long-term outcomes of complex prosthetic graft.
Vascular Surgery Michael Ricci, MD.
Clinical Engagement 15th July 2015 Robin A Howe
Endocarditis is an inflammation of the endocardium, the membrane lining the chambers of the heart and covering the cusps of the heart valves. Infective.
DCD Hope, H Wang, R Anders, P Villa, C Kong
MODERATE Risk 1 RISK FACTOR PRESENT Deformity OR Neuropathy OR Peripheral arterial disease No other risk factors x6 more likely to ulcerate Annual assessment.
Trust Induction Blackpool Victoria Hospital
Presentation transcript:

Treatment and Prophylaxis Guidelines – Where are we up to? Dr Jonathan Sandoe, Consultant Microbiologist, Leeds Management of infections in the vascular patient

Competing interests Paid by Pfizer to deliver a lecture on infections in vascular surgical patients in 2011 Research funding, sponsorship to attend conferences or deliver lectures from Novartis, Pfizer and Merck Sharp and Dohme, Biomet.

Infections in vascular patients Aim To persuade you that guidelines have a role in the management of infections in vascular surgical patients… BUT Only if used in the correct context and as part of a comprehensive infection service.

Infections in vascular patients Plan Part 1 – Treatment guideline update Part 2 – What do we want from guidelines? Part 3 – Prophylaxis guideline update

Part 1 Treatment guideline update

Guidelines for diagnosis and management of infected vascular grafts…

Guidelines for radiological diagnosis and management of infected (mycotic) aneurysms….

Infections in vascular patients Where are all the guidelines?

Part 2 What do we want from guidelines?

Infections in vascular patients The aim of treatment To cure patients of infection with minimal risk of harm in the most efficient way possible. Secondary aim…to suppress infection…

Infections in vascular patients The aim of guidelines To standardise and optimise the care of vascular patients with infection?

Infections in vascular surgery The aim of guidelines Is standardisation possible in complex infection?

Infections in vascular patients The aim of guidelines Can anything be standardised? Diagnostic criteria Initial investigations Microbiological processing Empirical antimicrobial therapy Directed antimicrobials Surgery?

Infections in vascular patients Guideline criticisms Too many Conflicting Unhelpful Difficult to follow Ignored Hard to find Out of date …….

IDSA: Antibiotic choice for DFI Adapted from Lipsky (2004) IDSA guidelines: diabetic foot infection.Clin Infect Dis 39: 885–910

Infections in vascular patients Guideline criticisms NICE: AB - Diabetic foot infection (DFI) NICE are unable to make any recommendations on individual agents Each hospital should have DFI guidelines.

Infections in vascular patients Making the task manageable Infections can be viewed as “specialty- specific” and “general” In the assessment of a vascular surgery inpatient with infection, the differential diagnosis may be broad...

Infections in vascular patients “Specialty specific” infections 1.Surgical site infection (wound, stump, early graft infection) 2.Vascular graft infection (early/late) 3.AV fistula infection 4.Mycotic aneurysms 5.Diabetic foot infection 6.Cellulitis/ulcer infection

8179 Jan July 2008 “Hits” on antimicrobial guidelines per month

Infections in vascular patients Contrasting - situations Mycotic aneurysmVascular graft infection Microbiologymonomicrobialpolymicrobial Microbiological diagnosis (Blood culture) reliableunreliable ComorbidityIE, IVDU, noneDM, PVD, CKD Prosthetic materialabsentpresent

Infections in vascular patients Infected aneurysms yearlocationCauseIntervention 12012cerebralStrep gordoniiNone splenicStrep oralisRadiological embolisation brachialStrep agalactiaeResection/repair

Vascular graft infection Guideline – “top level recommendations” Antimicrobial strategy determined by surgical strategy Surgical strategy determined by location of graft, patient choice/suitability for surgery…. Removal of infected graft and debridement of infected tissue appears to be necessary for cure?

Vascular graft infection Success of surgical strategy for infection 1. Removal and extra-anatomical bypass 2. Removal with replacement with autologous vessel 3. Partial removal and replacement 4. Endovascular arterial reconstruction 5. No surgery

Vascular graft infection Duration of therapy vs surgical strategy 1.Removal/extra anatomical 6/52 IV 2.Removal/ in situ autologous 6/52 IV/po 3.Partial removal 6/52 IV + suppression? 4.EVAR 6/52 IV + suppression 5.No surgery IV + suppression

Vascular graft infection Guideline – Antimicrobial treatment Is it appropriate to draw parallels between prosthetic valve endocarditis and vascular graft infection? Prolonged (6/52) IV antimicrobials can cure PVE Trial data needed

Vascular graft infection Empirical therapy 1.Vancomycin + piperacillin/tazobactam (appropriate spectrum, low CDI risk, low MRSA colonisation risk)* 2.Vancomycin + ciprofloxacin +metronidazole (penicillin allergic patient)* (antifungals?) *Empirical regimen should consider previous microbiology

Part 3 Guidelines for antimicrobial prophylaxis in vascular (surgery) patients

Infections in vascular patients Prophylaxis Peripheral arterial reconstruction (EL 1+)

Do not use antibiotic prophylaxis routinely for clean non-prosthetic uncomplicated surgery (!) DO for all implant surgery Infections in vascular patients Prophylaxis

single dose prophylaxis IV on starting anaesthesia (earlier for operations in which a tourniquet is used). Infections in vascular patients Prophylaxis

No recommendations on choice of agent “see local formulary” Infections in vascular patients Prophylaxis

Infections in vascular patients Summary Guidelines do have a role in the management of infections in vascular surgical patients… BUT Only if used in the correct context and as part of a comprehensive infection service. More data are needed – high quality observational studies if trials impractical.